Marie Overgaard

19.6k total citations · 4 hit papers
139 papers, 12.5k citations indexed

About

Marie Overgaard is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Marie Overgaard has authored 139 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Cancer Research, 49 papers in Oncology and 36 papers in Surgery. Recurrent topics in Marie Overgaard's work include Breast Cancer Treatment Studies (62 papers), Head and Neck Cancer Studies (32 papers) and Breast Lesions and Carcinomas (28 papers). Marie Overgaard is often cited by papers focused on Breast Cancer Treatment Studies (62 papers), Head and Neck Cancer Studies (32 papers) and Breast Lesions and Carcinomas (28 papers). Marie Overgaard collaborates with scholars based in Denmark, Norway and United Kingdom. Marie Overgaard's co-authors include Jens Overgaard, Søren M. Bentzen, Henning T. Mouridsen, Carsten Rose, C. Gadeberg, Michael Kjær, Maj‐Britt Jensen, Hanne Melgaard Nielsen, Per Syrak Hansen and Marianne Nordsmark and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Marie Overgaard

136 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy

1997 1.9k citations Marie Overgaard, Per Syrak Hansen et al. profile →
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

1999 1.2k citations Marie Overgaard, Maj‐Britt Jensen et al. The Lancet profile →
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1996 812 citations Marie Overgaard, Jens Overgaard et al. Radiotherapy and Oncology profile →
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

2003 481 citations Jens Overgaard, Hanne Sand Hansen et al. The Lancet profile →

Peers

Countries citing papers authored by Marie Overgaard

Since Specialization

Citations

This map shows the geographic impact of Marie Overgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Overgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Overgaard more than expected).

Fields of papers citing papers by Marie Overgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Overgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Overgaard. The network helps show where Marie Overgaard may publish in the future.

Co-authorship network of co-authors of Marie Overgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Overgaard. A scholar is included among the top collaborators of Marie Overgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Overgaard. Marie Overgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1–3 Positive Lymph Nodes? 2011 ·Breast Care ·Birgitte Vrou Offersen, (unknown), Mette Møller Nielsen, Jens Overgaard, Marie Overgaard	6
2	The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – Results from the randomized DAHANCA 5 study 2010 ·Radiotherapy and Oncology ·Camilla Molich Hoff, Hanne Sand Hansen, Marie Overgaard, Cai Grau, Jørgen Johansen, Jens Bentzen, Jens Overgaard	52
3	Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group 2008 ·Journal of Clinical Oncology ·Marianne Kyndi, Flemming Brandt Sørensen, Helle Knudsen, Marie Overgaard, Hanne Melgaard Nielsen, Jens Overgaard	432
4	High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c 2008 ·Radiotherapy and Oncology ·Marianne Kyndi, Marie Overgaard, Hanne Melgaard Nielsen, Flemming Brandt Sørensen, Helle Knudsen, Jens Overgaard	82
5	Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms inTGFB1,SOD2,XRCC1,XRCC3,APEXandATMndash; a study based on DNA from formalin fixed paraffin embedded tissue samples 2006 ·International Journal of Radiation Biology ·Christian Nicolaj Andreassen, Jan Alsner, Marie Overgaard, Flemming Brandt Sørensen, Jens Overgaard	78
6	ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Christian Nicolaj Andreassen, Jens Overgaard, Jan Alsner, Marie Overgaard, Carsten Herskind, Jamie A. Cesaretti, David P. Atencio, Sheryl Green, Silvia C. Formenti, Richard G. Stock, Barry S. Rosenstein	76
7	Radiotherapy as part of a multidisciplinary treatment strategy in early breast cancer 2001 ·European Journal of Cancer ·Marie Overgaard	14
8	Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment Alone 2000 ·Acta Oncologica ·Inger Højris, Jörn Andersen, Marie Overgaard, Jens Overgaard	102
9	Treatment Morbidity Associated with the Management of the Axilla in Breast-Conserving Therapy 2000 ·Acta Oncologica ·Jørgen Johansen, Jens Overgaard, M Blichert-Toft, Marie Overgaard	95
10	Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial breakdown → 1999 ·The Lancet ·Marie Overgaard, Maj‐Britt Jensen, Jens Overgaard, Per Syrak Hansen, Carsten Rose, Michael Andersson, Claus Kamby, Michael Kjær, C. Gadeberg, Birgitte Rasmussen, M Blichert-Toft, Henning T. Mouridsen	1203
11	Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group 1999 ·European Journal of Cancer ·Michael Andersson, Ebbe Lindegaard Madsen, Marie Overgaard, Carsten Rose, P Dombernowsky, Henning T. Mouridsen	22
12	Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck 1998 ·Radiotherapy and Oncology ·Morten Høyer, Karsten Juhl Jørgensen, Troels Bundgaard, Lars Vendelbo Johansen, Søren M. Bentzen, Marie Overgaard, Olfred Hansen, H. Søgaard, Jens Overgaard	29
13	Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays 1998 ·International Journal of Radiation Biology ·Jørgen Johansen, C. Streffer, (unknown), Søren M. Bentzen, Brian Stausbøl‐Grøn, Marie Overgaard, Jens Overgaard	23
14	Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation 1997 ·Radiotherapy and Oncology ·Olfred Hansen, Jens Overgaard, (unknown), Marie Overgaard, Morten Høyer, (unknown), Lars Bastholt, Anne Berthelsen	121
15	Evidence for a Positive Correlation between in Vitro Radiosensitivity of Normal Human Skin Fibroblasts and the Occurrence of Subcutaneous Fibrosis after Radiotherapy 1994 ·International Journal of Radiation Biology ·Jørgen Johansen, Søren M. Bentzen, Jens Overgaard, Marie Overgaard	107
16	A Randomized Feasibility Study Evaluating the Effect of Radiotherapy Alone Or Combined with 5-Fluorouracil in the Treatment of Locally Recurrent Or Inoperable Colorectal Carcinoma 1993 ·Acta Oncologica ·Marie Overgaard, K. Bertelsen, M. Dalmark, C. Gadeberg, Hans von der Maase, Jens Overgaard, A Sell	36
17	Early and Late Normal Tissue Injury after Postmastectomy Radiotherapy 1993 ·Recent results in cancer research ·Søren M. Bentzen, Marie Overgaard	27
18	Auditory brain stem responses in patients after radiation therapy for nasopharyngeal carcinoma 1992 ·Cancer ·Cai Grau, (unknown), Marie Overgaard, Jens Overgaard, (unknown)	12
19	[Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1]. 1991 ·PubMed ·(unknown), (unknown), (unknown), Axelsson Ck, M Blichert-Toft, P Dombernowsky, (unknown), (unknown), Mouridsen Ht, Marie Overgaard	1
20	Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85 1991 ·Radiotherapy and Oncology ·Jens Overgaard, Hanne Sand Hansen, Birgit Lindeløv, Marie Overgaard, Karsten Juhl Jørgensen, Bente Rasmusson, A Berthelsen	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact